vimarsana.com

Equities Research Analysts’ updated eps estimates for Tuesday, May 24th: Central Garden & Pet (NASDAQ:CENTA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $45.00 price target on the stock. According to Zacks, “Central Garden & Pet Company is a leading innovator, marketer […]

Related Keywords

Nevada ,United States ,Wanchai ,Hong Kong General ,Hong Kong ,United Kingdom ,Texas ,China ,California ,San Diego ,Wisconsin ,Oakville ,Rehovot ,Hamerkaz ,Israel ,Germany ,Netherlands ,Ireland ,Spain ,America ,Chinese ,Las Vegas ,Power Digital Infrastructure Acquisition Corp ,Curiositystream Inc ,Collplant Biotechnologies Ltd ,Community Healthcare Trust ,Collplant Holdings Ltd ,Cellectar Biosciences Inc ,Cardiol Therapeutics Inc ,Central Garden Pet Company ,Core Scientific Holding Co ,Cv Sciences ,Composecure Inc ,Equities Research Analyst ,Ceragon Networks ,Zacks Investment Research ,Novelos Therapeutics Inc ,Cv Sciences Inc ,Software Acquisition Group Inc ,Ceragon Networks Ltd ,Mtech Acquisition Corp ,Community Healthcare Trust Incorporated ,Investment Research ,Pet Company ,Healthcare Trust ,Healthcare Trust Incorporated ,Plant Biotechnologies ,Plant Biotechnologies Ltd ,Biosciences Inc ,Novelos Therapeutics ,Secure Inc ,Acquisition Corp ,Scientific Holding ,Digital Infrastructure Acquisition Corp ,Cardiol Therapeutics ,Resources Beer ,Resources Enterprise ,Qstream Inc ,Middle East ,Latin America ,Central Garden Pet ,Canopy Growth Co ,Core Scientific Inc ,Crh Plc ,China Resources Beer Holdings Company Limited ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.